


<!DOCTYPE html>
<html lang="en-GB">
    <head>
        <title>Spinraza access agreement extended  | News and features | News | NICE</title>
        <!--[if lt IE 9]>
        <script src="//alpha-cdn.nice.org.uk/global-nav/global-nav.ie8.min.js"></script>
        <![endif]-->
        <link href="//fonts.googleapis.com/css?family=Lato:400,700,900" rel="stylesheet" type="text/css" />
<link href="/css/app.css" rel="stylesheet" type="text/css" />
<!--[if lt IE 9]>
<link href="/niceorg-client/ie8/css" rel="stylesheet" type="text/css" />
<![endif]-->
<!--[if lt IE 9]>
<script src="//cdn.nice.org.uk/V2/Scripts/html5shiv/html5shiv.js" type="text/javascript"></script>
<![endif]-->
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/jquery/jquery-1.12.4.min.js" type="text/javascript"></script>
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/head.combined-v1.10.8001.0.js" type="text/javascript"></script>




    <!-- addthis config -->
    <script>
        var addthis_config = {
            data_ga_property: 'UA-28620212-2',
            data_ga_social: true,
            ui_show_promo: false,
            services_compact: '',
            pubid: 'ra-5506be4a13ce4bf0'
        };
        $(function () {
            if (typeof addthis !== "undefined") { // may be undefined if tracker-blockers enabled
                addthis.init();
            }
        });
    </script>
    <!-- end addthis config -->


        
  <meta charset="utf-8" />
  <meta name="X-UA-Compatible" content="IE=edge,chrome=1" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta property="og:locale" content="en_GB" />
  <meta name="x-country" content="gb" />
  <meta name="DC.Title" content="Spinraza access agreement extended  | News and features | News | NICE" />
  <meta property="og:title" content="Spinraza access agreement extended" />
  <meta name="twitter:title" content="Spinraza access agreement extended" />
  <meta name="msapplication-TileColor" content="#f6f6f6" />
  <meta name="msapplication-TileImage" content="//cdn.nice.org.uk/V3/Content/nice/favicon-144.png" />
  <meta name="DC.Publisher" content="NICE" />
  <meta name="DC.Rights.Copyright" content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." />
  <meta name="DC.Language" scheme="DCTERMS.ISO639-2T" content="eng" />
  <meta name="DC.Subject" scheme="eGMS.IPSV" content="Health, well-being and care" />
  <meta name="eGMS.accessibility" scheme="eGMS.WCAG10" content="Double-A" />
  <meta property="og:site_name" content="NICE" />
  <meta name="twitter:site" content="@NICEcomms" />
  <meta name="twitter:creator" content="@NICEcomms" />
  <meta name="twitter:card" content="summary" />
  <meta property="og:url" content="https://alpha.nice.org.uk/news/article/nice-recommends-first-ever-treatment-for-children-with-rare-muscle-wasting-condition" />
  <meta property="og:type" content="article" />
  <meta property="article:author" content="https://www.facebook.com/NationalInstituteforHealthandCareExcellence" />
  <meta name="cid" content="114121" />
  <meta name="DC.Issued" scheme="DCTERMS.W3CDTF" content="2019-07-03" />
  <meta name="DC.Modified" scheme="DCTERMS.W3CDTF" content="2019-07-04" />
  <meta name="DC.Type" scheme="NICE.Publication.Types" content="NewsArticle"/>
  <meta property="og:image" content="https://alpha.nice.org.uk/Media/Default/NewsItem/NewsArticleImage/nusinersen%20spinraza.png" />
  <meta property="og:image:secure_url" content="https://alpha.nice.org.uk/Media/Default/NewsItem/NewsArticleImage/nusinersen%20spinraza.png" />
  <meta name="twitter:image" content="https://alpha.nice.org.uk/Media/Default/NewsItem/NewsArticleImage/nusinersen%20spinraza.png" />


        
        <link rel="shortcut icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon.ico" />
        <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon-precomposed" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png">
        <link rel="apple-touch-icon" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png">
        <link rel="apple-touch-icon-precomposed" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
            <link rel="canonical" href="https://alpha.nice.org.uk/news/article/nice-recommends-first-ever-treatment-for-children-with-rare-muscle-wasting-condition" />
        <!--[if IE 6]><script>var ieVersion = 6;</script><![endif]-->
        <!--[if IE 7]><script>var ieVersion = 7;</script><![endif]-->
        <!--[if IE 8]><script>var ieVersion = 8;</script><![endif]-->
        

<script>     (function(h,o,t,j,a,r){         h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};         h._hjSettings={hjid:119167,hjsv:5};         a=o.getElementsByTagName('head')[0];         r=o.createElement('script');r.async=1;         r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;         a.appendChild(r);     })(window,document,'//static.hotjar.com/c/hotjar-','.js?sv='); </script><meta name="theme-color" content="#333"> <!-- Start Visual Website Optimizer Asynchronous Code -->         <script type='text/javascript'>             var _vwo_code=(function(){             var account_id=257258, _vis_opt_url = window._vis_opt_url || document.URL,             settings_tolerance=2000,             library_tolerance=2500,             use_existing_jquery=false,             /* DO NOT EDIT BELOW THIS LINE */             f=false,d=document;return{use_existing_jquery:function(){return use_existing_jquery;},library_tolerance:function(){return library_tolerance;},finish:function(){if(!f){f=true;var a=d.getElementById('_vis_opt_path_hides');if(a)a.parentNode.removeChild(a);}},finished:function(){return f;},load:function(a){var b=d.createElement('script');b.src=a;b.type='text/javascript';b.innerText;b.onerror=function(){_vwo_code.finish();};d.getElementsByTagName('head')[0].appendChild(b);},init:function(){settings_timer=setTimeout('_vwo_code.finish()',settings_tolerance);var a=d.createElement('style'),b='body{opacity:0 !important;filter:alpha(opacity=0) !important;background:none !important;}',h=d.getElementsByTagName('head')[0];a.setAttribute('id','_vis_opt_path_hides');a.setAttribute('type','text/css');if(a.styleSheet)a.styleSheet.cssText=b;else a.appendChild(d.createTextNode(b));h.appendChild(a);this.load('//dev.visualwebsiteoptimizer.com/j.php?a='+account_id+'&u='+encodeURIComponent(_vis_opt_url)+'&r='+Math.random());return settings_timer;}};}());_vwo_settings_timer=_vwo_code.init();         </script>         <!-- End Visual Website Optimizer Asynchronous Code --><link href="https://www.nice.org.uk/Media/Default/css/default.css" rel="stylesheet" type="text/css" /><script src="https://www.nice.org.uk/Media/Default/js/default.js" type="text/javascript"></script>

    </head>

 
<body data-spy="scroll" data-target=".aside-primary" class=" " >
<!-- Google Tag Manager -->
    <noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-M55QTQ"
                height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                    new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
                    j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                        '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-M55QTQ');</script>
<!-- End Google Tag Manager -->


    <div id="global-nav-header"></div>

    

<div id="printpane"></div>
    <header class="container  ">
<div class="zone zone-breadcrumb">

<div class="widget-breadcrumb widget-sub-menu-widget widget">
    <div class="widget-content">
      
<div class="container">
   
<ul class="breadcrumb"> 
    <li><a href="/" data-track="mainbreadcrumb">Home</a><i class="divider icon-nice-chevron-right"></i></li>

        <li class="active"><a href="/news" data-track="mainbreadcrumb">News</a></li>
</ul>


    <h1 id="content-start">Spinraza access agreement extended </h1>

    <h2 class="lead">More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza after NICE today (3 July) published amended draft guidance following a proposal for extending the terms of the managed access agreement (MAA) between NHS England and Biogen for funding it. </h2>
    <p class="pull-left mr--d"><time datetime="2019-07-03">03 July 2019</time></p>

<div class="share-links navbar pull-left">
    <div class="navbar-inner">
        <ul class="unstyled">
           <li class="dropdown">
                
               <a href="#" id="nice-share" class="btn-sharelink dropdown-toggle" data-toggle="dropdown" title="Share">
                    <span>Share</span></a>                 <ul class="dropdown-menu pull-left addthis_toolbox" role="menu" aria-labelledby="nice-share">
                <li class="nav-header"><b>Share</b></li>
                    <!-- AddThis Button BEGIN -->
                    <li><a class="addthis_button_linkedin" ><i class="icon-linkedin"></i> Linked In</a></li>
                    <li><a class="addthis_button_twitter" ><i class="icon-nice-twitter"></i> Twitter</a></li>
                    <li><a class="addthis_button_facebook" ><i class="icon-nice-facebook"></i> Facebook</a></li>
                    <li><a class="addthis_button_email"><i class="icon-nice-email-closed"></i> Email</a></li>
                    <li><a class="addthis_button_more"><i class="icon-nice-plus"></i> More...</a></li>
                    <!-- AddThis Button END -->
                </ul>
            </li>
        </ul>
    </div>
</div>




</div>
    </div>
  </div></div>            </header>
<div id="toTop"><i aria-hidden="true" class="icon-nice-chevron-up"></i></div>
<div class="layout ">
    <div class="content content-primary">
            <div id="layout-messages">
                <div class="zone zone-messages"><div id="messages-container"></div></div>
            </div>
                        <div class="zone zone-content">

<article class="news-content">
        <div class="row">
            <div class="span8">
                <p>The company made the proposal taking into consideration further clinical evidence<sup>i</sup>. The MAA has also been refined in light of a number of requests for clarification.</p>
<p>The most significant change to the MAA is that it will now include paediatric patients who have recently (in the previous 12 months) lost the ability to walk independently. This replaces the previous criteria that patients, who had previously gained ambulation, should still be able to walk independently at the start of their treatment with Spinraza.</p>
<p>Spinraza (also called nusinersen) is the first treatment that targets the underlying cause of SMA.</p>
<p>SMA affects the nerves in the spinal cord controlling movement. This causes muscle weakness, progressive loss of movement, and difficulty breathing and swallowing.</p>
<p>People with the most severe forms of SMA usually die before the age of 2. Without nusinersen the condition is managed through supportive care which aims to minimise the impact of disability, address complications and improve quality of life.</p>
<p>It is estimated there are there are between 600 and 1200 children and adults in the UK living with SMA.</p>
<p>Today&rsquo;s announcement follows the agreement of a revised deal between NHS England and Biogen which will see the NHS fund treatment with Spinraza for a time-limited period, allowing further data to be collected on its effectiveness.</p>
<p><strong>Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE, said:&nbsp;</strong>&ldquo;Having considered new evidence about the effectiveness of Spinraza in people who have lost the ability to walk, NHS England and Biogen have been able to find a way forward that all parties are happy with and that will ensure Spinraza is available to as many people with SMA as possible.</p>
<p>&ldquo;There will still be people with SMA who will not be able to access treatment with Spinraza under the terms of this agreement. But we are not closing the door to these people. Uniquely for this type of arrangement we have made a commitment that, during the 5-year course of the MAA, should evidence become available on the potential benefits of Spinraza for type III SMA patients that are currently not included in the MAA, we will review that evidence to see whether it would support a change in the MAA inclusion criteria.&rdquo;</p>
<p>NICE will now update its draft guidance to reflect the new MAA criteria and this will be issued to consultees for appeal. If no appeals are received, final guidance is expected to be published at the end of July.</p>
<p>NHS England will provide information about the availability of nusinersen,&nbsp;under the terms of the MAA, to the youngest and most severely affected (SMA type 1) patients.</p>
<p>&nbsp;</p>
<p>References</p>
<p>Darras et al, 2019 <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541434/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541434/</a></p>                     
            </div>
            <div class="span4">
                <img src="https://www.nice.org.uk/Media/Default/_Profiles\2eff655c\6a40a9c6\nusinersen spinraza.png" alt="" />
            </div>
        </div>  
</article></div>            </div>
            <div class="content content-secondary">
            <div class="zone zone-aside-second">
    <blockquote>
        <p>Having considered new evidence about the effectiveness of Spinraza in people who have lost the ability to walk, NHS England and Biogen have been able to find a way forward all parties are happy with</p>
            <footer><cite title="Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE"><strong>Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE</strong></cite></footer>    
    </blockquote>    



<aside class="over-fill">

</aside>


<div class="widget-aside-second widget-related-content-widget widget">
    <div class="widget-content">
      





    </div>
  </div>

<div class="widget-aside-second widget-related-links-extended-widget widget">
    <div class="widget-content">
      




    </div>
  </div>

<div class="widget-aside-second widget-related-resources-widget widget">
    <div class="widget-content">
      

    <div class="aside-panel">
        <h3>Related Resources</h3>
        <div class="well">    
            <ul class="media-list">
                    <li class="media"><a class="media-title" href="https://www.nice.org.uk/guidance/indevelopment/gid-ta10281/documents">Read the amended managed access agreement for Spinraza here:</a></li>
            </ul>
        </div>
    </div>




    </div>
  </div>

<div class="widget-aside-second widget-related-links-widget widget">
    <div class="widget-content">
      





    </div>
  </div></div>
        </div> <!-- content secondary -->
</div>
<!-- layout -->

<div class="zone zone-footer">

<div class="widget-footer widget-footer widget-html-widget widget">
    <div class="widget-content">
      <footer class="footer-wrapper-new" style="position: relative;">
<div class="footer">
<div class="container no-left-margin">
<div class="row">
<div class="span3" id="main-nav">
<div class="row">
<div class="span12"><a href="/" aria-label="Go to NICE home page" class="footer-nicelogo"><i aria-hidden="true" class="logo icon-nice-logo"><span class="logotext">NICE</span></i></a>
<ul class="unstyled main-nav-panel">
<li><a href="/about">About NICE</a></li>
<li><a href="/about/what-we-do/into-practice" title="Communities">Into practice</a></li>
<li><a href="/news">News</a></li>
<li><a href="/get-involved/contact-us">Contact us</a></li>
<li><a href="/leave-feedback">Leave feedback</a></li>
<li><a href="/get-involved/jobs">Jobs</a></li>
</ul>
</div>
</div>
<div class="row">
<div class="span12" id="social">
<ul class="unstyled">
<li><a href="http://www.nice.org.uk/news/nice-newsletters-and-alerts"> <i class="icon-nice-readnews"></i>Newsletters and alerts</a></li>
<li><a href="https://www.nice.org.uk/news/blog"> <i class="icon-nice-user"></i> Blog </a></li>
<li><a href="//twitter.com/NICEcomms?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor"><i class="icon-nice-twitter"></i>Twitter</a></li>
<li><a href="//www.youtube.com/user/NICEmedia"><i class="icon-youtube-play fa"></i>YouTube</a></li>
<li><a href="https://en-gb.facebook.com/NationalInstituteforHealthandCareExcellence/"><i class="icon-nice-facebook"></i>&nbsp; Facebook</a></li>
<li><a href="//www.linkedin.com/company/national-institute-for-health-and-clinical-excellence"><i class="icon-linkedin-sign fa"></i>LinkedIn</a></li>
</ul>
</div>
</div>
</div>
<div class="span3" id="explore">
<h2 class="footer-collumn-title">Explore</h2>
<ul class="unstyled" id="explore-panel">
<li><a href="/guidance">Guidance</a></li>
<li><a href="//pathways.nice.org.uk">Pathways</a></li>
<li><a href="/standards-and-indicators">Standards and indicators</a></li>
<li><a href="//www.evidence.nhs.uk/">Evidence search</a></li>
<li><a href="https://bnf.nice.org.uk">BNF</a></li>
<li><a href="https://bnfc.nice.org.uk/">BNFC</a></li>
<li><a href="https://cks.nice.org.uk">Clinical knowledge summaries</a></li>
<li><a href="/about/what-we-do/evidence-services/journals-and-databases">Journals and databases</a></li>
</ul>
</div>
<div class="span3" id="syndication">
<h2 class="footer-collumn-title"><a href="/re-using-our-content">Reusing our content</a></h2>
<ul class="unstyled" id="reuse-panel">
<li><a href="/re-using-our-content">Reuse information</a></li>
<li><a href="/re-using-our-content/uk-open-content-licence">NICE UK Open Content Licence</a></li>
</ul>
</div>
<div id="get-involved">
<div class="span3">
<h2 class="footer-collumn-title"><a href="/get-involved" title="Get involved">Get involved</a></h2>
<ul class="unstyled" id="get-involved-panel">
<li><a href="/get-involved/stakeholder-registration">Register as a stakeholder</a></li>
<li><a href="/get-involved/citizens-council">Citizens council</a></li>
<li><a href="/get-involved/consultations">Consultations</a></li>
<li><a href="/get-involved/fellows-and-scholars">Fellows and scholars</a></li>
<li><a href="/get-involved/our-committees/join-a-committee">Join a committee</a></li>
<li><a href="/get-involved/meetings-in-public">Meetings in public</a></li>
<li><a href="/get-involved/student-champions">Student champions</a></li>
<li><a href="/get-involved/tenders">Tenders</a></li>
<li><a href="https://www.nice.org.uk/about/nice-communities/nice-and-the-public">NICE and the public</a></li>
</ul>
</div>
</div>
</div>
</div>
<div class="container line-div  hidden-phone">
<div class="row">
<div class="line"></div>
</div>
</div>
<div class="legal-panel">
<div class="container">
<ul class="nav nav-legal">
<li><a href="/accessibility">Accessibility</a></li>
<li><a href="/freedom-of-information">Freedom of information</a></li>
<li><a href="/about/what-we-do/nice-syndication-api">Syndication services</a></li>
<li><a href="/glossary">Glossary</a></li>
<li><a href="/terms-and-conditions">Terms and conditions</a></li>
<li><a href="/privacy-notice">Privacy notice</a></li>
<!--<li><a href="/help">Help</a></li>--></ul>
<p class="legal-copyright">&copy; NICE [year]. All rights reserved. Subject to <a href="/terms-and-conditions#notice-of-rights">Notice of rights</a>.</p>
</div>
</div>
</div>
</footer>
<script>// <![CDATA[
var cpy = document.getElementsByClassName("legal-copyright")[0];
cpy.innerHTML = cpy.innerHTML.replace("[year]", new Date().getFullYear());
// ]]></script>
    </div>
  </div></div>
    <!--[if lt IE 9]>
<script src="//cdnjs.cloudflare.com/ajax/libs/respond.js/1.4.2/respond.min.js" type="text/javascript"></script>
<![endif]-->
<script src="//cdn.nice.org.uk/V2/Scripts/twitter.bootstrap.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V2/Scripts/NICE.bootstrap.min.js" type="text/javascript"></script>
<script type="text/javascript"></script>
<script src="https://www.nice.org.uk/Modules/Orchard.Resources/scripts/history.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V3/Scripts/nice/NICE.EventTracking.js" type="text/javascript"></script>
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/niceorg/NICE.TopScroll.js" type="text/javascript"></script>
<script src="//s7.addthis.com/js/300/addthis_widget.js#async=1" type="text/javascript"></script>
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/foot.combined-v1.10.8001.0.js" type="text/javascript"></script>


    <script>
        var global_nav_config = {
            service: "",
            header: {
                skipLinkId: "content-start",
                search: {
                    url: "/search",
                    autocomplete: "/autocomplete?ajax=ajax",
                    query: ""
                },
                auth: {
                    environment: "beta"
                }
            },
            footer: false
        };
    </script>

    <script src="//alpha-cdn.nice.org.uk/global-nav/global-nav.min.js" defer></script>

        <script type="text/javascript">
            $(document).ajaxSend(function (event, jqxhr, settings) {
                if (settings.url.indexOf("?") >= 0) {
                    settings.url = settings.url + "&ajax=ajax";
                } else {
                    settings.url = settings.url + "?ajax=ajax";
                }
            })
            if ('ontouchstart' in document.documentElement) {
                $('body').addClass('touch-screen-device');
            } else {
                $('body').addClass('non-touch-screen-device');
            }
        </script>
</body>

</html>

